A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer

Weihong Zhang, Jing Qin, Jing Luo, Yanjuan Xiong, Fan Yang, Bin Li, Meng Shen, Huizhen Geng, Zibo Li, Xiao Tian, Shuzhan Li, Runmei Li, Yang Wang, Xinwei Zhang, Xiubao Ren, Qian Sun, Li Zhou, Liang Liu

Open source

DOI: 10.1007/s00262-026-04338-7
Published: 2026-03-11
Container: Cancer Immunology, Immunotherapy
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00262-026-04338-7,
  title = {A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer},
  author = {Weihong Zhang and Jing Qin and Jing Luo and Yanjuan Xiong and Fan Yang and Bin Li and Meng Shen and Huizhen Geng and Zibo Li and Xiao Tian and Shuzhan Li and Runmei Li and Yang Wang and Xinwei Zhang and Xiubao Ren and Qian Sun and Li Zhou and Liang Liu},
  year = {2026},
  journal = {Cancer Immunology, Immunotherapy},
  doi = {10.1007/s00262-026-04338-7},
  url = {https://doi.org/10.1007/s00262-026-04338-7}
}

RIS

TY  - JOUR
TI  - A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer
AU  - Weihong Zhang
AU  - Jing Qin
AU  - Jing Luo
AU  - Yanjuan Xiong
AU  - Fan Yang
AU  - Bin Li
AU  - Meng Shen
AU  - Huizhen Geng
AU  - Zibo Li
AU  - Xiao Tian
AU  - Shuzhan Li
AU  - Runmei Li
AU  - Yang Wang
AU  - Xinwei Zhang
AU  - Xiubao Ren
AU  - Qian Sun
AU  - Li Zhou
AU  - Liang Liu
PY  - 2026
JO  - Cancer Immunology, Immunotherapy
DO  - 10.1007/s00262-026-04338-7
UR  - https://doi.org/10.1007/s00262-026-04338-7
ER  -

APA

Zhang, W., Qin, J., Luo, J., Xiong, Y., Yang, F., Li, B., Shen, M., Geng, H., Li, Z., Tian, X., Li, S., Li, R., Wang, Y., Zhang, X., Ren, X., Sun, Q., Zhou, L., & Liu, L. (2026). A single-arm phase Ib study of personalized peptide-pulsed dendritic cell-based multiple target cytotoxic T lymphocyte immunotherapy in combination with toripalimab as second-line therapy in advanced non-small-cell lung cancer. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04338-7

Source records

crossref · retrieved 2026-09-25T21:18:47.871Z